Frontiers in Pharmacology (Nov 2021)
Corrigendum: Schisandrin B Antagonizes Cardiotoxicity Induced by Pirarubicin by Inhibiting Mitochondrial Permeability Transition Pore (mPTP) Opening and Decreasing Cardiomyocyte Apoptosis
- Hongwei Shi,
- Hongwei Shi,
- Heng Tang,
- Wen Ai,
- Qingfu Zeng,
- Hong Yang,
- Fengqing Zhu,
- Yunjie Wei,
- Rui Feng,
- Li Wen,
- Peng Pu,
- Quan He
Affiliations
- Hongwei Shi
- Department of Radiation Oncology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
- Hongwei Shi
- Department of Oncology, Renmin Hospital of Wuhan University, Wuhan, China
- Heng Tang
- Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
- Wen Ai
- Shenzhen Nanshan District People’s Hospital, Shenzhen, China
- Qingfu Zeng
- Department of Vascular Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China
- Hong Yang
- Department of Endocrine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
- Fengqing Zhu
- Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
- Yunjie Wei
- Department of Cardiology, Hubei Shiyan Taihe Hospital, Shiyan, China
- Rui Feng
- Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
- Li Wen
- Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
- Peng Pu
- Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
- Quan He
- Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
- DOI
- https://doi.org/10.3389/fphar.2021.796551
- Journal volume & issue
-
Vol. 12
Abstract
No abstracts available.Keywords
